On September 18th, at the 5th China Conference At the awarding ceremony of Shandong Postdoctoral Innovation and Entrepreneurship Competition, Dr. Peng Chuantao, the founder of Yuanda Biology, won the gold medal of the entrepreneurship team of the competition for his "Targeting Functional Postdoctoral Research and Development and Industrialization", and will represent the Shandong provincial team in the national competition of "Postdoctoral" entrepreneurship and innovation competition. Once the news came out, it was highly concerned by all sectors of society and major mainstream media, and made the headline of the program of Shandong News Network. When the program was broadcast, it focused on the gold medal project of Dr. Peng and others.

As the first national high-tech enterprise in China to focus on the research and promotion of probiotic derived cell technology, as well as a model of industry university research integration, Yuanda Biotechnology has always been committed to promoting the upgrading and technological breakthroughs of the derived cell industry, and building a leading brand in China's derived cell raw materials and functional derived cell terminal products. Adhering to the original intention of "more delicious and healthier", we continue to create scientific and technological achievements in the field of post production, steadily promote the development and application of post production products, and provide a complete set of terminal product solutions for the production of post production functional foods, post production anti dark and stomach protecting drinks, post production skincare products, post production children's daily chemical products, post production feed and other products.

Persist in technological innovation and stand at the forefront of the emerging talent market

Technological innovation is the lifeline of sustainable development for enterprises and a key element in enhancing core competitiveness. Over the years, Yuanda Biotech has maintained a high level of R&D investment and continuously strengthened its research capabilities. Since the beginning of its entrepreneurship in 2021, Yuanda Biotechnology has won multiple product awards in the emerging industry at the national, provincial, and ministerial levels, thanks to its strong technical strength and continuously innovative products. Its independent research achievements have been rated as international leading level, and it has led or participated in more than 10 national and provincial level projects in related fields. It has published more than 40 high-level papers in SCI TOP journals, SCI, and EI, authorized more than 10 patents, and won 7 awards at or above the provincial and ministerial level. It has also formed a professional research and development and technological innovation team of more than 28 people.

Yuanda Biological Honor Wall

Yuanda Biotechnology has gained high recognition in the industry for its excellent market reputation, innovative "targeted functional epigenetic strain resource library construction", "targeted functional epigenetic key preparation technology", "efficacy evaluation and product development", and "epigenetic mechanism analysis", as well as its high-end epigenetic core technology and innovative performance. With outstanding technical and innovative capabilities, it has been unanimously recognized by investors, partners, news media, and various sectors of society.

In recent years, it has been a critical juncture of opportunities and challenges for the field of post biotics. Yuanda Biotech has paid close attention to the research and development of probiotics, post biotics and other microbial market trends, and has successively developed targeted functional skincare raw materials, post biotics Bilantera ®、 Biological preservatives+cleaning labels+prebiotic raw materials PostbioYDFF ®、 Postbiocare, a type of substance that protects the stomach from harmful effects ® Such epigenetic raw materials can replace or reduce the use of chemical preservatives, antibiotics, etc., and have actually applied and launched such blockbuster products as epigenetic soothing facial mask, Bloomberg Prebiotic Postbiocare anti quiet drink, Bloomberg Prebiotic Children's Anti caries Toothpaste, and epigenetic Children's Teeth Care spray, which enrich the product layout of enterprises in the industry market, and help the product landing with two innovative models, namely, the one-stop solution of "targeting epigenetic research and development" and the new economic business of "epigenetic industrialization development".

The product is the core competitiveness of the enterprise, and the recently launched Postbiocare, a derivative of the anti dark and stomach protecting product, has been introduced ® The raw material is a leader in the field of post biotics - Dr. Peng Chuantao and his team from Yuanda Biotechnology have relied on their more than 10 years of technology in the field of post biotics and microbiology to research proprietary products extracted and prepared by screening strains from their own collection of bacteria through compound fermentation. After a series of clinical studies on the effectiveness and safety of anti Helicobacter pylori infection, Postbiocare has been determined ® It has strong high targeting ability and can specifically bind to Helicobacter pylori, inhibit its adhesion and proliferation growth with gastric mucosal epithelial cells, form aggregates and be excreted through the digestive tract, achieving effective anti Helicobacter pylori and good safety, compliance, clinical feasibility and other functional purposes. It is also clear that it may be used as an adjuvant therapy for the treatment of Helicobacter pylori infection and related diseases (such as functional dyspepsia, gastritis and gastric ulcers, superficial gastritis, gastroesophageal reflux, etc.), or as an important new alternative to anti Helicobacter pylori therapy in populations that are not suitable for antibiotic treatment.

Under the new opportunities and challenges, Yuanda Biotechnology actively adapts to changes in industry, market, regulations, and customer needs, actively participates in various competitions, continuously enhances core technologies, meets customer consumption needs, and creates technological value for the emerging Yuanda industry.

At this award ceremony, Dr. Peng Chuantao and his project from Yuanda Biotechnology were officially awarded the Gold Medal Honor Certificate and Trophy. This is a recognition from all walks of life for Yuanda Biotechnology's efforts in creating and implementing targeted functional meta products, as well as a high degree of recognition for Yuanda Biotechnology's continuous promotion of technological innovation and deepening of industry development influence.

In the future, Yuanda Biotechnology will adhere to the vision of "developing and producing world-class young generation cells", leverage its own advantages, provide fertile ground for scientific research and innovation, focus on the research and promotion of young generation cell technologies, and the application and landing of young generation cell research achievements, contributing Yuanda's technological strength to the young generation cell industry and a healthy China in 2023.